Detalhe da pesquisa
1.
Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.
Virol J;
21(1): 82, 2024 04 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38589848
2.
Expert opinion on the identification, risk assessment, and mitigation of microorganisms and parasites relevant to xenotransplantation products from pigs.
Xenotransplantation;
30(5): e12815, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37616183
3.
The Effect of Mice Adaptation Process on the Pathogenicity of Influenza A/South Africa/3626/2013 (H1N1)pdm09 Model Strain.
Int J Mol Sci;
24(24)2023 Dec 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38139214
4.
The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children.
Clin Infect Dis;
69(5): 786-794, 2019 08 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30481269
5.
Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh.
Clin Infect Dis;
69(5): 777-785, 2019 08 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30481272
6.
M2e-based universal influenza vaccines: a historical overview and new approaches to development.
J Biomed Sci;
26(1): 76, 2019 Oct 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31629405
7.
H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.
Mol Ther;
24(5): 991-1002, 2016 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26796670
8.
A novel immunofluorescent test system for SARS-CoV-2 detection in infected cells.
PLoS One;
19(5): e0304534, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38820303
9.
Development of Cross-Reactive Live Attenuated Influenza Vaccine Candidates against Both Lineages of Influenza B Virus.
Vaccines (Basel);
12(1)2024 Jan 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38250908
10.
Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium.
J Virol;
86(21): 11725-34, 2012 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22915797
11.
Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines.
Vaccines (Basel);
11(12)2023 Nov 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38140152
12.
Overview of Nucleocapsid-Targeting Vaccines against COVID-19.
Vaccines (Basel);
11(12)2023 Dec 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38140214
13.
Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model.
Viruses;
15(1)2023 01 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36680269
14.
Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein.
Vaccines (Basel);
11(3)2023 Feb 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36992084
15.
RDE Treatment Prevents Non-Specific Detection of SARS-CoV-2- and Influenza-Specific IgG Antibodies in Heat-Inactivated Serum Samples.
Antibodies (Basel);
12(2)2023 Jun 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37366655
16.
Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets.
J Infect Dis;
204(10): 1491-9, 2011 Nov 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21957153
17.
Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests.
Viruses;
14(9)2022 09 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36146847
18.
Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview.
Viruses;
14(5)2022 05 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35632823
19.
Understanding the Variability of Certain Biological Properties of H1N1pdm09 Influenza Viruses.
Vaccines (Basel);
10(3)2022 Mar 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35335027
20.
In Vitro Stimulation with Live SARS-CoV-2 Suggests Th17 Dominance In Virus-Specific CD4+ T Cell Response after COVID-19.
Vaccines (Basel);
10(9)2022 Sep 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36146622